QCG
TMDX icon

Quadrant Capital Group’s Transmedics TMDX Stock Holding History

Quadrant Capital Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$760K Sell
7,647
-34
-0.4% -$4.43K 0.02% 691
2025
Q4 		$934K Sell
7,681
-2
-0% -$251 0.03% 591
2025
Q3 		$862K Buy
7,683
+71
+0.9% +$8.31K 0.03% 581
2025
Q2 		$1.02M Buy
7,612
+184
+2% +$20.2K 0.04% 473
2025
Q1 		$500K Buy
7,428
+7,134
+2,427% +$491K 0.02% 738
2024
Q4 		$18.3K Buy
294
+265
+914% +$24.7K ﹤0.01% 1929
2024
Q3 		$4.55K Buy
29
+4
+16% +$616 ﹤0.01% 2341
2024
Q2 		$3.77K Buy
25
+3
+14% +$360 ﹤0.01% 2362
2024
Q1 		$1.63K Hold
22
– – ﹤0.01% 2538
2023
Q4 		$1.74K Sell
22
-1
-4% -$60 ﹤0.01% 2497
2023
Q3 		$1.26K Sell
23
-158
-87% -$11.4K ﹤0.01% 2459
2023
Q2 		$15.2K Buy
181
+33
+22% +$2.53K ﹤0.01% 1837
2023
Q1 		$11.2K Buy
148
+114
+335% +$7.88K ﹤0.01% 1982
2022
Q4 		$2.1K Sell
34
-17
-33% -$904 ﹤0.01% 2397
2022
Q3 		$2K Buy
+51
New +$2.22K ﹤0.01% 2433
2021
Q4 		– Sell
-18
Closed -$1K – 2696
2021
Q3 		$1K Buy
+18
New +$550 ﹤0.01% 2397

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quadrant Capital Group's TMDX Position: Q1 2026 in Review

Quadrant Capital Group reduced its Transmedics (TMDX) stake by 0.44% in Q1 2026, selling an estimated $4.43K and leaving 7,647 shares worth $760K. The position accounts for 0.02% of the portfolio, ranked #691.

Quadrant Capital Group first reported a position in TMDX in Q3 2021 and has held it in 16 quarters since. The position peaked at $1.02M in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Quadrant Capital Group held 7,647 shares of Transmedics worth $760K as of Q1 2026.
  • Quadrant Capital Group sold 34 Transmedics shares in Q1 2026, an estimated $4.43K.
  • Transmedics made up 0.02% of Quadrant Capital Group's portfolio in Q1 2026, its #691 holding.
  • Quadrant Capital Group first reported a position in Transmedics in Q3 2021 and has held it in 16 quarters since.
  • Quadrant Capital Group's Transmedics position peaked at $1.02M in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.